042520 — HANS BIOMED Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapMomentum Trap

Annual balance sheet for HANS BIOMED, fiscal year end - September 30th, KRW millions except per share, conversion factor applied.

	2020 September 30th	2021 September 30th	2022 September 30th	2023 September 30th	2024 September 30th
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	22,862	20,268	13,553	7,048	7,259
Net Total Accounts Receivable
Net Total Receivables	15,526	9,983	10,529	13,114	12,138
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	58,696	51,113	54,371	50,393	49,707
Net Property, Plant And Equipment	47,247	46,591	46,934	44,234	43,523
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	131,806	129,445	131,686	122,368	121,715
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	28,092	60,991	74,443	65,253	50,092
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	71,470	84,994	86,052	73,239	54,841
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	60,336	44,451	45,634	49,129	66,874
Total Liabilities & Shareholders' Equity	131,806	129,445	131,686	122,368	121,715
Total Common Shares Outstanding